Academic institutions grant commercial license for CRISPR-based SHERLOCK diagnostic technology in developed world
Rights are protected for broad use in developing world and for public health needs.
Rights are protected for broad use in developing world and for public health needs.
CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox.
Forbes calls its 2019 30 Under 30 honorees “a collection of bold risk-takers who are putting a new twist on the old tools of the trade.”
McGovern Institute scientist is recognized with award for outstanding and creative achievements made in the life and medical sciences.
Research team shows the power of proteomics to discover new drug targets and help develop therapeutic strategies with fewer long-term side effects.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Three MIT faculty members selected for funding from the G. Harold and Leila Y. Mathers Foundation.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.
MIT researchers find that encountering novel contexts cues the brain to churn out neurogranin.
MIT faculty members are among 19 top scientists selected from across the nation.
Finkelstein, Kardar, Wen, and Zhang honored for research achievements.
Prestigious honor society announces 213 new members this year.
Novel technology could allow researchers to develop and test new antimalaria drugs.